"Evolving regulatory requirements, heightened scrutiny from regulatory agencies, and geopolitical uncertainties pose challenges"

Strides Pharma Science demerged its Contract Development and Manufacturing Organisation (CDMO) business into OneSource Specialty Pharma Ltd, following approval by the National Company Law Tribunal (NCLT) in 2024.

- 

OneSource Specialty Pharma, was listed on January 22, 2025 on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). With a revenue generation of around Rs 1500 crore during FY 2024-25, the company is providing seamless end-to-end offerings across all verticals (biologics, drug-device combinations, sterile injectables and Softgel capsules). In an interaction with BioSpectrum India, Neeraj Sharma, CEO & Managing Director, OneSource Specialty Pharma, upbeat about the growth of the CDMO sector, reveals more about the company's major focus areas in the coming years. Edited excerpts:

What have been the major highlights for this fiscal, and what are your upcoming plans?

This fiscal has been marked by significant milestones, namely the successful merger of the three incoming businesses, fundraising with participation from marquee investors, successful listing on the NSE and the BSE and significant addition to our customer base. The listing of OneSource Pharma on the NSE and BSE this year, marks a significant milestone in our journey, one that began with a vision to build a one-stop shop for the CDMO sector. Listing will increase our visibility among partners and stakeholders, opening up more opportunities for strategic collaborations and business ventures. It will also support the recruitment of talent from around the globe. The group is known for its strong corporate governance. We now have over 60 customers across all modalities and now we collaborate with 20 customers in the GLP-1 space. We have initiated our first new biological entity (NBE) programme with the top three animal health companies. Additionally, we are supporting seven potential new chemical entity (NCE)-1 programmes.